The market capitalization for Stryker Corporation (SYK) is $119.06 Billion, making it a Large Cap company. Market cap is calculated by multiplying the current stock price by the total number of shares outstanding.
Market Capitalization
$119.06B
$119.06 Billion
Calculation
- Stock Price
- $310.58
- Shares Outstanding
- 383.36M
- Market Cap
- $119.06B
Market Cap = Price × Shares Outstanding
Size Classification
Large Cap
$10B - $1T
Companies with market capitalization between $10 billion and $1 trillion.
Market Cap Size Scale
Micro Cap
<$250M
Small Cap
$250M-$2B
Mid Cap
$2B-$10B
Large Cap
$10B-$1T
Mega Cap
>$1T
Related Valuation Metrics
Key Statistics
| Market Cap | $119.06 Billion |
| Stock Price | $310.58 |
| Shares Outstanding | 383.36M |
| Size Category | Large Cap |
| P/E Ratio | 35.95 |
| P/B Ratio | 5.22 |
About Stryker Corporation
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kevin A. Lobo